Vaccines (Nov 2022)

Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells

  • Timothy Connelley,
  • Annalisa Nicastri,
  • Tara Sheldrake,
  • Christina Vrettou,
  • Andressa Fisch,
  • Birkir Reynisson,
  • Soren Buus,
  • Adrian Hill,
  • Ivan Morrison,
  • Morten Nielsen,
  • Nicola Ternette

DOI
https://doi.org/10.3390/vaccines10111907
Journal volume & issue
Vol. 10, no. 11
p. 1907

Abstract

Read online

The apicomplexan parasite Theileria parva is the causative agent of East Coast fever, usually a fatal disease for cattle, which is prevalent in large areas of eastern, central, and southern Africa. Protective immunity against T. parva is mediated by CD8+ T cells, with CD4+ T-cells thought to be important in facilitating the full maturation and development of the CD8+ T-cell response. T. parva has a large proteome, with >4000 protein-coding genes, making T-cell antigen identification using conventional screening approaches laborious and expensive. To date, only a limited number of T-cell antigens have been described. Novel approaches for identifying candidate antigens for T. parva are required to replace and/or complement those currently employed. In this study, we report on the use of immunopeptidomics to study the repertoire of T. parva peptides presented by both BoLA-I and BoLA-DR molecules on infected cells. The study reports on peptides identified from the analysis of 13 BoLA-I and 6 BoLA-DR datasets covering a range of different BoLA genotypes. This represents the most comprehensive immunopeptidomic dataset available for any eukaryotic pathogen to date. Examination of the immunopeptidome data suggested the presence of a large number of coprecipitated and non-MHC-binding peptides. As part of the work, a pipeline to curate the datasets to remove these peptides was developed and used to generate a final list of 74 BoLA-I and 15 BoLA-DR-presented peptides. Together, the data demonstrated the utility of immunopeptidomics as a method to identify novel T-cell antigens for T. parva and the importance of careful curation and the application of high-quality immunoinformatics to parse the data generated.

Keywords